- Home
- MASI vs ITCI Comparison
MASI vs ITCI Comparison
Compare MASI & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASI
- ITCI
- Stock Information
- Founded
- MASI 1989
- ITCI 2002
- Country
- MASI United States
- ITCI United States
- Employees
- MASI N/A
- ITCI N/A
- Industry
- MASI Medical/Dental Instruments
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- MASI Health Care
- ITCI Health Care
- Exchange
- MASI Nasdaq
- ITCI Nasdaq
- Market Cap
- MASI 9.3B
- ITCI 8.0B
- IPO Year
- MASI 2007
- ITCI N/A
- Fundamental
- Price
- MASI $170.97
- ITCI $84.85
- Analyst Decision
- MASI Buy
- ITCI Strong Buy
- Analyst Count
- MASI 7
- ITCI 12
- Target Price
- MASI $179.67
- ITCI $97.67
- AVG Volume (30 Days)
- MASI 446.0K
- ITCI 457.2K
- Earning Date
- MASI 02-25-2025
- ITCI 02-20-2025
- Dividend Yield
- MASI N/A
- ITCI N/A
- EPS Growth
- MASI N/A
- ITCI N/A
- EPS
- MASI 1.45
- ITCI N/A
- Revenue
- MASI $2,042,600,000.00
- ITCI $613,728,000.00
- Revenue This Year
- MASI $3.85
- ITCI $48.41
- Revenue Next Year
- MASI $2.26
- ITCI $38.26
- P/E Ratio
- MASI $118.05
- ITCI N/A
- Revenue Growth
- MASI N/A
- ITCI 46.08
- 52 Week Low
- MASI $101.61
- ITCI $62.78
- 52 Week High
- MASI $180.97
- ITCI $93.45
- Technical
- Relative Strength Index (RSI)
- MASI 55.02
- ITCI 50.70
- Support Level
- MASI $166.70
- ITCI $82.76
- Resistance Level
- MASI $173.26
- ITCI $86.36
- Average True Range (ATR)
- MASI 5.11
- ITCI 2.53
- MACD
- MASI -1.25
- ITCI -0.05
- Stochastic Oscillator
- MASI 33.86
- ITCI 44.91
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.